SVB Wealth’s Mustang Bio MBIO Stock Holding History

SVB Wealth’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20	Closed	-$50K	–	1032
2021 Q2	$50K	Hold	20	–	–	﹤0.01%	943
2021 Q1	$50K	Hold	20	–	–	﹤0.01%	882
2020 Q4	$57K	Buy	+20	New	+$47.8K	﹤0.01%	812

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SVB Wealth's MBIO Position: Q3 2021 in Review

SVB Wealth sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 20 shares — an estimated $50K sold.

SVB Wealth first reported a position in MBIO in Q4 2020 and held it in 3 quarters. The position peaked at $57K in Q4 2020. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

SVB Wealth reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
SVB Wealth sold 20 Mustang Bio shares in Q3 2021, an estimated $50K.
SVB Wealth first reported a position in Mustang Bio in Q4 2020 and held it in 3 quarters.
SVB Wealth's Mustang Bio position peaked at $57K in Q4 2020.
79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on SVB Wealth's 13F filing for Q3 2021, filed 9 Nov 2021.